Skip to main content

Chugai Licenses Genedata's Software

NEW YORK (GenomeWeb News) – Tokyo-based Chugai Pharmaceutical has signed a multi-year license agreement with Genedata for the use of its biomarker discovery software in R&D programs, the Swiss bioinformatics company said today.

Genedata said that Chugai has already been using the Expressionist software to normalize its microarray data pool, to standardize its microarray quality control process, and to obtain data for analysis.

Using the software to handle data from "tens of thousands" of data sets, Chugai's bioinformatics team member Junichi Muroya said in a statement, has "increased processing speed, facilitated sophisticated statistical analysis and overall improved the quality of our results significantly."

Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.